Rubio-Viqueira B - Search Results

1

A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry.

Angulo B, Conde E, Suárez-Gauthier A, Plaza C, Martínez R, Redondo P, Izquierdo E, Rubio-Viqueira B, Paz-Ares L, Hidalgo M, López-Ríos F. Angulo B, et al. PLoS One. 2012;7(8):e43842. doi: 10.1371/journal.pone.0043842. Epub 2012 Aug 27. PLoS One. 2012. PMID: 22952784 Free PMC article.

2

The ALK translocation in advanced non-small-cell lung carcinomas: preapproval testing experience at a single cancer centre.

Conde E, Angulo B, Izquierdo E, Muñoz L, Suárez-Gauthier A, Plaza C, Dominguez N, Torres M, Madrigal L, Rubio-Viqueira B, Belda-Iniesta C, Hidalgo M, López-Ríos F. Conde E, et al. Histopathology. 2013 Mar;62(4):609-16. doi: 10.1111/his.12037. Epub 2013 Feb 5. Histopathology. 2013. PMID: 23379755 Free article.

3

The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung.

Conde E, Angulo B, Redondo P, Toldos O, García-García E, Suárez-Gauthier A, Rubio-Viqueira B, Marrón C, García-Luján R, Sánchez-Céspedes M, López-Encuentra A, Paz-Ares L, López-Ríos F. Conde E, et al. PLoS One. 2010 Aug 17;5(8):e12209. doi: 10.1371/journal.pone.0012209. PLoS One. 2010. PMID: 20808915 Free PMC article.

4

Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.

Rubio-Viqueira B, Hidalgo M. Rubio-Viqueira B, et al. Clin Pharmacol Ther. 2009 Feb;85(2):217-21. doi: 10.1038/clpt.2008.200. Epub 2008 Nov 12. Clin Pharmacol Ther. 2009. PMID: 19005462 Review. No abstract available.

5

Current status of mammalian target of rapamycin inhibitors in lung cancer.

Gómez-Martín C, Rubio-Viqueira B, Hidalgo M. Gómez-Martín C, et al. Clin Lung Cancer. 2005 Sep;7 Suppl 1:S13-8. doi: 10.3816/clc.2005.s.003. Clin Lung Cancer. 2005. PMID: 16159415 Review.

6

Primary human non-small cell lung and pancreatic tumorgraft models--utility and applications in drug discovery and tumor biology.

Calles A, Rubio-Viqueira B, Hidalgo M. Calles A, et al. Curr Protoc Pharmacol. 2013 Jun;Chapter 14:Unit 14.26. doi: 10.1002/0471141755.ph1426s61. Curr Protoc Pharmacol. 2013. PMID: 23744711

7

A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.

Jimeno A, Feldmann G, Suárez-Gauthier A, Rasheed Z, Solomon A, Zou GM, Rubio-Viqueira B, García-García E, López-Ríos F, Matsui W, Maitra A, Hidalgo M. Jimeno A, et al. Mol Cancer Ther. 2009 Feb;8(2):310-4. doi: 10.1158/1535-7163.MCT-08-0924. Epub 2009 Jan 27. Mol Cancer Ther. 2009. PMID: 19174553 Free PMC article.

8

Targeting mTOR for cancer treatment.

Rubio-Viqueira B, Hidalgo M. Rubio-Viqueira B, et al. Curr Opin Investig Drugs. 2006 Jun;7(6):501-12. Curr Opin Investig Drugs. 2006. PMID: 16784020 Review.

9

Targeting mTOR for cancer treatment.

Rubio-Viqueira B, Hidalgo M. Rubio-Viqueira B, et al. Adv Exp Med Biol. 2006;587:309-27. doi: 10.1007/978-1-4020-5133-3_24. Adv Exp Med Biol. 2006. PMID: 17163174 Review.

10

New scaffolds for the design of selective estrogen receptor modulators.

Martín-Santamaría S, Rodríguez JJ, de Pascual-Teresa S, Gordon S, Bengtsson M, Garrido-Laguna I, Rubio-Viqueira B, López-Casas PP, Hidalgo M, de Pascual-Teresa B, Ramos A. Martín-Santamaría S, et al. Org Biomol Chem. 2008 Oct 7;6(19):3486-96. doi: 10.1039/b806918b. Epub 2008 Aug 4. Org Biomol Chem. 2008. PMID: 19082149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters